Element E: Clinical and Translational Science Research Program
The Consortium for Translational and Precision Health’s (CTPH) Clinical and Translational Science Research Program supports research addressing key challenges in clinical and translational science.
The goal of the Clinical and Translational Science Research Program is to develop, demonstrate and disseminate innovations that accelerate clinical and translational science at UM1 CTSA Program Hubs.
Element E is a component of the Clinical and Translational Science Program and will support discrete research projects that address a significant challenge in clinical and translational science. Projects should not only answer a translational research question within a specific disease or intervention but also generate generalizable clinical and translational science innovations or insights that can advance the overall efficiency or effectiveness of clinical and translational science across CTSA UM1 Program Hubs.
Successful projects for the 2026 cycle are expected to lay the groundwork for future adoption and dissemination across the CTSA Program Hubs. Funding is available through this mechanism for up to $150,000 per year in direct cost for two-three years given appropriate budget justification.
Collaboration with other CTPH modules, programs and collaborators is expected.
If you have any questions regarding the Clinical and Translational Science Research Program and application process, please contact CTPH@bcm.edu.
Request for Applications
-
2026 Request for Applications
Review the full request for applications for complete information about the 2026 cycle.
-
Submission Portal
Letter of Intent Due: Sunday, April 26, 2026, 11:59 p.m. CT.
Program Awardees
-
Tools & Methods for Automated Cleaning, Annotating and Summarizing EHR Data
Thom Taylor, Ph.D.; Andrew Zimolzak, MD; Bo Peng, Ph.D.; Brian Reed, MD
Baylor College of Medicine and University of Houston
Sign Up
If you’re interested in news and opportunities from CTPH, sign up for our communications.